T0	Participants 48 100	patients with type 2 diabetes in the PROactive Study
T1	Participants 211 240	Patients with type 2 diabetes
T2	Participants 570 610	high-risk patients with type 2 diabetes.
T3	Participants 672 749	5238 patients with type 2 diabetes who had evidence of macrovascular disease.
T4	Participants 763 814	patients from primary-care practices and hospitals.
T5	Participants 1549 1569	514 of 2605 patients
T6	Participants 2410 2485	patients with type 2 diabetes who have a high risk of macrovascular events.